Cresco Labs (CRLBF) Income towards Parent Company (2020 - 2026)
Cresco Labs (CRLBF) reported Income towards Parent Company of -$13.1 million for Q1 2026, up 9.42% on a YoY basis from -$11.9 million in Q1 2025, and up 84.68% quarter-over-quarter from -$85.3 million in Q4 2025.
Cresco Labs (CRLBF) Income towards Parent Company (2020 - 2026) Analysis & Trends
Cresco Labs has reported Income towards Parent Company for 7 years, with the latest figure at -$13.1 million in Q1 2026.
- For the quarter ending Q1 2026, Income towards Parent Company rose 9.42% year-over-year to -$13.1 million; the trailing twelve-month figure through Mar 2026 stood at -$131.8 million (down 78.99% YoY), and the FY2025 full-year result was -$140.0 million, down 131.52% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$13.1 million, up from -$85.3 million in the prior quarter.
- The five-year high for Income towards Parent Company was $5.7 million in Q4 2024, with the low at -$161.3 million in Q4 2022.
- Historically, Income towards Parent Company has averaged -$35.2 million across 5 years, with a median of -$16.3 million in 2025.
- Annual changes were most pronounced in 2024 — Income towards Parent Company jumped 115.22% — and 2025, when it slumped 1604.87%.
- Cresco Labs' Income towards Parent Company stood at -$161.3 million in 2022, then soared by 101.63% to $2.6 million in 2023, then soared by 115.22% to $5.7 million in 2024, then tumbled by 1604.87% to -$85.3 million in 2025, then soared by 84.68% to -$13.1 million in 2026.
- The last three Income towards Parent Company figures came in at -$13.1 million (Q1 2026), -$85.3 million (Q4 2025), and -$17.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.07 Mn |
| Dec 31, 2025 | -85.34 Mn |
| Sep 30, 2025 | -17.05 Mn |
| Jun 30, 2025 | -16.33 Mn |
| Mar 31, 2025 | -14.43 Mn |
| Dec 31, 2024 | 5.67 Mn |
| Sep 30, 2024 | -10.54 Mn |
| Jun 30, 2024 | -54.33 Mn |
| Mar 31, 2024 | -5.19 Mn |
| Dec 31, 2023 | 2.64 Mn |
| Sep 30, 2023 | -115.57 Mn |
| Jun 30, 2023 | -36.53 Mn |
| Mar 31, 2023 | -26.05 Mn |
| Dec 31, 2022 | -161.34 Mn |
| Sep 30, 2022 | -9.79 Mn |
| Jun 30, 2022 | -13.54 Mn |
| Mar 31, 2022 | -27.38 Mn |
| Dec 31, 2021 | -624.46 Mn |
| Sep 30, 2021 | 270.65 Mn |
| Jun 30, 2021 | -4.83 Mn |